In conclusion, while albendazole is a vital medication for treating various parasitic infections, the price and overall accessibility remain significant challenges, especially in low-income countries. Ensuring that the medication is affordable and available through various initiatives is essential for improving public health outcomes. Continued collaboration among governments, health organizations, and pharmaceutical companies will be critical in tackling the barriers to access, ultimately leading to a healthier population less burdened by parasitic diseases.